FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
218772NDASCIENTURE001ARBLISUSPENSION;ORAL10MG/MLLOSARTAN POTASSIUM2025-03-13PrescriptionYes
215487NDASCIENTURE001REZENOPYSPRAY;NASAL10MG/SPRAYNALOXONE HYDROCHLORIDE2024-04-19DiscontinuedNo